Chemours (CC) News Today $13.26 +0.10 (+0.72%) As of 03:37 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CC Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Chemours (NYSE:CC) Given New $16.00 Price Target at MizuhoJuly 15 at 11:19 AM | marketbeat.comPrincipal Financial Group Inc. Buys 399,097 Shares of The Chemours Company (NYSE:CC)July 15 at 3:26 AM | marketbeat.comTeacher Retirement System of Texas Buys Shares of 58,994 The Chemours Company (NYSE:CC)July 15 at 3:25 AM | marketbeat.comWhat is Zacks Research's Estimate for Chemours Q4 Earnings?July 13 at 2:01 AM | americanbankingnews.comWhat is Zacks Research's Forecast for Chemours Q2 Earnings?July 12, 2025 | americanbankingnews.comWhat is Zacks Research's Forecast for Chemours Q4 Earnings?July 11, 2025 | marketbeat.comM&T Bank Corp Cuts Holdings in The Chemours Company (NYSE:CC)July 11, 2025 | marketbeat.comChemours (NYSE:CC) Stock Price Up 6.4% - What's Next?July 10, 2025 | marketbeat.comChemours surges to highest since March as EPA pulls plan to rewrite asbestos phaseout rule - Seeking AlphaJuly 10, 2025 | seekingalpha.comEquities Analysts Issue Forecasts for Chemours Q2 EarningsJuly 10, 2025 | marketbeat.comThe Chemours Company (NYSE:CC) Stake Reduced by Amalgamated BankJuly 10, 2025 | marketbeat.comChemours (CC) Surges 9.7% as EPA Withdraws Ban on Chrysotile AsbestosJuly 9, 2025 | insidermonkey.comTwelve Points Wealth Management LLC Has $1.65 Million Stake in The Chemours Company (NYSE:CC)July 9, 2025 | marketbeat.comChemical stocks on the rise after new use rules withdrawn by EPAJuly 9, 2025 | msn.comChemours Stock Short Interest Report | NYSE:CC - BenzingaJuly 8, 2025 | benzinga.comChemours surges to highest since March as EPA pulls plan to rewrite asbestos phaseout ruleJuly 8, 2025 | seekingalpha.comChemours (NYSE:CC) Shares Gap Up - Here's WhyJuly 8, 2025 | marketbeat.comPekin Hardy Strauss Inc. Takes Position in The Chemours Company (NYSE:CC)July 7, 2025 | marketbeat.comThe Chemours Company (CC) Cash Flow - Yahoo FinanceJuly 3, 2025 | finance.yahoo.comChemours (CC) Maintains Outperform Rating with Raised Price Target | CC Stock NewsJuly 3, 2025 | gurufocus.comChemours (NYSE:CC) Price Target Raised to $15.00July 3, 2025 | marketbeat.comChemours (NYSE:CC) Stock Price Up 5.6% - Still a Buy?July 1, 2025 | marketbeat.comState of Alaska Department of Revenue Buys 65,751 Shares of The Chemours Company (NYSE:CC)June 26, 2025 | marketbeat.comCC The Chemours Company - Seeking AlphaJune 24, 2025 | seekingalpha.comThe Chemours Company (NYSE:CC) Given Consensus Rating of "Moderate Buy" by BrokeragesJune 22, 2025 | marketbeat.comSG Americas Securities LLC Invests $822,000 in The Chemours Company (NYSE:CC)June 20, 2025 | marketbeat.comChemours Guides for 2Q Sales at High End of Prior ForecastJune 18, 2025 | marketwatch.comChemours foresees strong Q2 sales increase on strong refrigerant demandJune 18, 2025 | msn.comChemours (NYSE:CC) Shares Gap Down - What's Next?June 18, 2025 | marketbeat.comThe Chemours Company Provides Update on Second Quarter 2025 OutlookJune 18, 2025 | businesswire.comMillennium Management LLC's Strategic Acquisition of The Chemours Co SharesJune 16, 2025 | gurufocus.comThe Chemours Company (NYSE:CC) Stock Holdings Decreased by Rhumbline AdvisersJune 14, 2025 | marketbeat.comFMR LLC Reduces Stake in The Chemours Co by 51.85%June 12, 2025 | gurufocus.comChemours names Matthew Conti as chief human resources officerJune 12, 2025 | investing.comChemours Appoints Matthew Conti as Chief Human Resources OfficerJune 12, 2025 | businesswire.comRecent uptick might appease The Chemours Company (NYSE:CC) institutional owners after losing 50% over the past yearJune 10, 2025 | finance.yahoo.comChemours Appoints Industry Vet Nathan Blom as Vice President of Liquid Cooling Growth PortfolioJune 10, 2025 | businesswire.comChemours Company (The) (CC) Stock ForecastsJune 6, 2025 | ca.finance.yahoo.comRFG Advisory LLC Makes New $968,000 Investment in The Chemours Company (NYSE:CC)June 6, 2025 | marketbeat.comInsider Buying: The Chemours Company (NYSE:CC) Insider Purchases 13,400 Shares of StockJune 5, 2025 | marketbeat.comDamian Gumpel Buys 7,822 Shares of The Chemours Company (NYSE:CC) StockJune 5, 2025 | marketbeat.comChemours (CC) Down 7.6% Since Last Earnings Report: Can It Rebound?June 5, 2025 | finance.yahoo.comChemours (NYSE:CC) Shares Up 7.4% After Insider Buying ActivityJune 5, 2025 | marketbeat.comDamian Gumpel Acquires 7,822 Shares of The Chemours Company (NYSE:CC) StockJune 5, 2025 | insidertrades.comChemours (NYSE:CC) Shares Down 6.4% - Here's WhyJune 3, 2025 | marketbeat.comChemours (NYSE:CC) Reaches New 52-Week Low - Here's What HappenedJune 3, 2025 | marketbeat.comNuveen Asset Management LLC Sells 57,329 Shares of The Chemours Company (NYSE:CC)June 1, 2025 | marketbeat.comThe Chemours Company (NYSE:CC) Shares Sold by Bank of America Corp DEJune 1, 2025 | marketbeat.comChemours (NYSE:CC) Price Target Cut to $13.00 by Analysts at BarclaysMay 29, 2025 | marketbeat.comThe Chemours Company (NYSE:CC) Receives Average Rating of "Moderate Buy" from BrokeragesMay 29, 2025 | marketbeat.com Get Chemours News Delivered to You Automatically Sign up to receive the latest news and ratings for CC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Videos CC Media Mentions By Week CC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CC News Sentiment▼0.330.58▲Average Basic Materials News Sentiment CC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CC Articles This Week▼198▲CC Articles Average Week Get Chemours News Delivered to You Automatically Sign up to receive the latest news and ratings for CC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ASIX News CE News DD News DOW News EMN News HUN News NTR News OLN News TROX News AXTA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:CC) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Chemours Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Chemours With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
